Top 5 Stocks to Buy Now
→ Iran War Shock: What I Was Told In That Private Meeting (From Banyan Hill Publishing) (Ad)tc pixel Free TRLS Stock Alerts

Trellus Health (TRLS) Competitors

GBX 0.12 0.00 (0.00%)
As of 06/19/2026
Compare

TRLS vs. IQAI, DVRG, SENS, EMIS, and CRW

Should you buy Trellus Health stock or one of its competitors? MarketBeat compares Trellus Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Trellus Health include IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), and Craneware (CRW). These companies are all part of the "health information services" industry.

How does Trellus Health compare to IQ-AI?

Trellus Health (LON:TRLS) and IQ-AI (LON:IQAI) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

IQ-AI has higher revenue and earnings than Trellus Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
IQ-AI£538.19K3.30N/AN/AN/A

Trellus Health has a beta of 2.509, meaning that its share price is 151% more volatile than the broader market. Comparatively, IQ-AI has a beta of 2.25, meaning that its share price is 125% more volatile than the broader market.

IQ-AI has a net margin of -77.52% compared to Trellus Health's net margin of -1,918.66%. Trellus Health's return on equity of -67.29% beat IQ-AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-1,918.66% -67.29% -22.76%
IQ-AI -77.52%-140.75%-22.03%

1.6% of Trellus Health shares are owned by institutional investors. 9.6% of Trellus Health shares are owned by company insiders. Comparatively, 66.0% of IQ-AI shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled IQ-AI'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
IQ-AI Neutral

Summary

IQ-AI beats Trellus Health on 5 of the 9 factors compared between the two stocks.

How does Trellus Health compare to DeepVerge?

DeepVerge (LON:DVRG) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, media sentiment, profitability, dividends, analyst recommendations, risk, valuation and institutional ownership.

DeepVerge has a net margin of -19.81% compared to Trellus Health's net margin of -1,918.66%. DeepVerge's return on equity of -10.27% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
DeepVerge-19.81% -10.27% -5.56%
Trellus Health -1,918.66%-67.29%-22.76%

DeepVerge has a beta of 1.07, suggesting that its stock price is 7% more volatile than the broader market. Comparatively, Trellus Health has a beta of 2.509, suggesting that its stock price is 151% more volatile than the broader market.

In the previous week, DeepVerge's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
DeepVerge Neutral
Trellus Health Neutral

4.2% of DeepVerge shares are owned by institutional investors. Comparatively, 1.6% of Trellus Health shares are owned by institutional investors. 9.5% of DeepVerge shares are owned by insiders. Comparatively, 9.6% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

DeepVerge has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than DeepVerge, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DeepVerge£12.41M0.00-£2.46M-£0.01N/A
Trellus Health£359K1.44-£7.98M-£5.00N/A

Summary

DeepVerge beats Trellus Health on 7 of the 10 factors compared between the two stocks.

How does Trellus Health compare to Sensyne Health?

Trellus Health (LON:TRLS) and Sensyne Health (LON:SENS) are both small-cap health information services industry companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

Sensyne Health has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Sensyne Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
Sensyne Health£7.81M0.00N/A-£22.10N/A

Sensyne Health has a net margin of 0.00% compared to Trellus Health's net margin of -1,918.66%. Sensyne Health's return on equity of 0.00% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-1,918.66% -67.29% -22.76%
Sensyne Health N/A N/A N/A

1.6% of Trellus Health shares are owned by institutional investors. 9.6% of Trellus Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Sensyne Health'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Sensyne Health Neutral

Summary

Sensyne Health beats Trellus Health on 5 of the 8 factors compared between the two stocks.

How does Trellus Health compare to EMIS Group?

Trellus Health (LON:TRLS) and EMIS Group (LON:EMIS) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, media sentiment, dividends, risk, profitability and institutional ownership.

EMIS Group has a net margin of 17.23% compared to Trellus Health's net margin of -1,918.66%. EMIS Group's return on equity of 23.17% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-1,918.66% -67.29% -22.76%
EMIS Group 17.23%23.17%7.99%

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled EMIS Group'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
EMIS Group Neutral

Trellus Health has a beta of 2.509, suggesting that its share price is 151% more volatile than the broader market. Comparatively, EMIS Group has a beta of -0.13, suggesting that its share price is 113% less volatile than the broader market.

EMIS Group has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than EMIS Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
EMIS Group£176.86M0.00£30.48M£0.47N/A

1.6% of Trellus Health shares are owned by institutional investors. Comparatively, 105.6% of EMIS Group shares are owned by institutional investors. 9.6% of Trellus Health shares are owned by insiders. Comparatively, 3.6% of EMIS Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Summary

EMIS Group beats Trellus Health on 8 of the 10 factors compared between the two stocks.

How does Trellus Health compare to Craneware?

Trellus Health (LON:TRLS) and Craneware (LON:CRW) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, media sentiment, risk, analyst recommendations, institutional ownership, profitability, valuation and earnings.

Trellus Health has a beta of 2.509, indicating that its share price is 151% more volatile than the broader market. Comparatively, Craneware has a beta of 0.28, indicating that its share price is 72% less volatile than the broader market.

Craneware has a consensus price target of GBX 2,297.75, indicating a potential upside of 69.05%. Given Craneware's stronger consensus rating and higher probable upside, analysts plainly believe Craneware is more favorable than Trellus Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Trellus Health
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Craneware
0 Sell rating(s)
0 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
3.00

Craneware has a net margin of 10.63% compared to Trellus Health's net margin of -1,918.66%. Craneware's return on equity of 6.65% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-1,918.66% -67.29% -22.76%
Craneware 10.63%6.65%2.28%

Craneware has higher revenue and earnings than Trellus Health. Trellus Health is trading at a lower price-to-earnings ratio than Craneware, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£359K1.44-£7.98M-£5.00N/A
Craneware£211.33M2.20£14.27M£62.9021.61

1.6% of Trellus Health shares are held by institutional investors. Comparatively, 36.4% of Craneware shares are held by institutional investors. 9.6% of Trellus Health shares are held by insiders. Comparatively, 10.3% of Craneware shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Craneware'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Craneware Neutral

Summary

Craneware beats Trellus Health on 13 of the 14 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

Export
MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£516K£347.89M£6.45B£2.78B
Dividend YieldN/A5.60%2.69%6.16%
P/E Ratio-0.02250.8724.92365.72
Price / Sales1.44132.06529.0186,253.69
Price / Cash0.7647.1444.8227.85
Price / Book0.017.3310.797.92
Net Income-£7.98M-£22.78M£3.56B£5.89B
7 Day PerformanceN/A-0.92%1.67%-0.87%
1 Month PerformanceN/A1.59%0.43%-0.76%
1 Year Performance-86.67%-10.58%32.84%70.67%

Trellus Health Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 0.12
flat		N/AN/A£516K£359KN/A31
IQAI
IQ-AI
N/AGBX 0.80
flat		N/A+0.0%£1.77M£538.19KN/A6
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41MN/A73
SENS
Sensyne Health
N/AN/AN/AN/A£583K£7.81MN/A70
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (LON:TRLS) was last updated on 6/23/2026 by MarketBeat.com Staff.
From Our Partners
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Do NOT Buy SpaceX – Do This Instead
SpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...
Stansberry Research | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
Porter flew 3,300 miles to investigate this system
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...
Porter & Company | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel